Company / Revenue per Share
DaVita Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$169.40
FY2025
5-year range
$103.59 / $169.40
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#15 of 153
Health Care
What the data says
Among 153 Health Care companies, DaVita is in the top 10% for revenue per share. Revenue per Share has increased for 9 consecutive years, from $52.26 in FY2016 to $169.40 in FY2025.
Based on SEC 10-K filings.
169.40 in FY2025 with a 5-year CAGR of +13.3%. Top quartile in the Health Care sector.
Improved from $128.51 to $169.40 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 153This company $169.40 Sector average $123.89
▼
+36.7% above sector average
Key checks
Key Insights
- DaVita's revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 17.4% year-over-year.
- Ranks #15 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $169.40 | +17.4% |
| FY2024 | $144.28 | +12.3% |
| FY2023 | $128.51 | +8.2% |
| FY2022 | $118.72 | +14.6% |
| FY2021 | $103.59 | +14.3% |
| FY2020 | $90.63 | +38.6% |
| FY2019 | $65.37 | +11.4% |
| FY2018 | $58.68 | +3.2% |
| FY2017 | $56.84 | +8.8% |
| FY2016 | $52.26 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026